Vanda Pharmaceuticals (VNDA) PT Raised to $7.50 at Jefferies
Tweet Send to a Friend
Jefferies analyst Chris Howerton raised the price target on Vanda Pharmaceuticals (NASDAQ: VNDA) to $7.50 (from $5.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
